Sansheng Guojian released its semi-annual report for 2026, achieving operating revenue of 866 million yuan, up 34.84% year on year. Net profit attributable to shareholders of the listed company was 371 million yuan, up 95.1% year on year. The company plans to distribute a cash dividend of 0.42 yuan per 10 shares, tax included, to all shareholders. Net profit for the second quarter was 193 million yuan, while net profit for the first quarter was 178 million yuan, meaning second-quarter net profit rose 8% quarter on quarter.
Sunshine Guojian Pharmaceutical Shanghai Co LtdNet profit up 95.1% YoY and revenue up 34.84% in H1 2026.
